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Objective: The purpose of this study was to determine the prevalence of significant carotid stenosis, to identify risk factors
increasing this prevalence, and to determine the risk of progression of stenosis, in patients with peripheral arterial
occlusive disease who are neurologically asymptomatic.
Study design: Consecutive patients who underwent evaluation in a vascular laboratory for peripheral arterial occlusive
disease, who had no recent neurologic symptoms, were investigated.
Results: From July 1999 to December 2000, 620 patients underwent duplex scanning on one occasion, and 417 on two
occasions. The average age was 72 10 years, and 61% were men. An occluded internal carotid artery was found in 4.8%
of patients. The prevalence of a carotid stenosis >50% was 33% on the initial evaluation. Age of more than 70 years (P 
.007), diabetes mellitus (P  .042), history of stroke (P  .011), and ankle/brachial index of less than 0.8 (P  .0006),
were independently associated with carotid stenosis >50%. The odds ratio associated with each of these risk factors was
similar. The prevalence of carotid stenosis >50% was 16%, 21%, 38%, 47%, and 44% for patients with no, one, two, three,
and four risk factors, respectively. The highest prevalence of carotid stenosis >50% was identified in patients with
ankle/brachial indices of less than 0.4 (59%). During the follow-up period, no patient had a cerebrovascular event. In 15%
of carotid arteries, progression from one class of stenosis to a more severe class was observed, and 6.5% of patients
progressed from a lower degree to 50% to 99% stenosis. No differences in progression of disease were identified when the
variables of age, diabetes, previous stroke, and ankle/brachial index of less than 0.8 were studied or when patients with
zero to two of these putative risk factors were compared with patients with three or four.
Conclusion: Screening for carotid stenosis in asymptomatic patients with peripheral vascular disease is justifiable, but not
mandatory, when two or more risk factors are present or when the ankle/brachial index is less than 0.4. Rates of
progression to clinically significant stenosis are low and do not justify reevaluation every 6 months. Further research to
identify the optimal interval for reevaluation is needed. (J Vasc Surg 2002;36:75-82.)
Controversy remains regarding the natural history and
optimal management of asymptomatic carotid stenosis.
Duplex ultrasonography, because of its sensitivity and spec-
ificity1,2 and the absence of risk associated with the test, is
ideally suited as a tool for diagnosis and monitoring in
asymptomatic patient populations. The purpose of investi-
gating carotid stenoses is to identify persons with signifi-
cant stenoses who are at increased risk of cerebrovascular
disease3,4 and who may benefit from carotid endarterec-
tomy. The prevalence of moderate-to-severe internal ca-
rotid artery stenosis, however, is low in unselected elderly
(70 years of age) healthy volunteers (1.5%; 95% CI, 2.6 to
9.0)5 and relatively low even in individuals with a cervical
bruit (21%; 95% CI, 18 to 24).6-8 Moreover, the absolute
benefit of carotid endarterectomy in individuals with
asymptomatic carotid stenosis is small and only marginally
statistically significant.9,10 Because of these considerations,
the role of noninvasive testing as a screening tool and the
appropriate interval for follow-up evaluation of patients
with moderate stenosis have not been defined.
We sought to answer these important questions by
prospectively studying a consecutive cohort of patients who
were neurologically asymptomatic and were referred to a
vascular laboratory for assessment of peripheral arterial
occlusive disease. The aims of the study were: 1, to deter-
mine the prevalence of hemodynamically significant carotid
stenosis in this patient population; 2, to identify risk factors
for carotid stenosis; 3, to determine the risk of progression
of stenosis; and 4, to assess the occurrence of neurologic
symptoms during follow-up study with usual medical man-
agement.
METHODS
This is a prospective cohort study of patients referred
for assessment of lower extremity peripheral arterial occlu-
sive disease by generalists and vascular surgeons to a vascu-
lar laboratory accredited by the Intersocietal Commission
for the Accreditation of Vascular Laboratory. In addition
to the noninvasive hemodynamic testing requested by the
referring physician, all patients also underwent carotid du-
plex ultrasonography. All results were reported to the re-
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ferring physician, but no attempt was made to alter man-
agement.
Inclusion and exclusion criteria. Consecutive pa-
tients referred for noninvasive evaluation of lower extremity
peripheral arterial occlusive disease on the basis of clinical
findings were included in the study. Patients were excluded
if they had neurologic symptoms or a documented neuro-
logic event within the 3 years before study entry.
Data collection. A standard questionnaire was used to
record demographic data and details of preexisting risk
factors (sex, age, diabetes mellitus, history of smoking,
hypertension, and prior stroke and coronary artery disease).
Duplex ultrasound scan (DUS) of the carotid arteries was
done at the time of entry in the study and repeated at 6 to
9 months by a registered vascular technologist. Color du-
plex scanning was used to investigate the carotid arteries
with a 5-MHz pulsed Doppler scan carrier, a 1.5-mm
cubed sample volume at a 60-degree angle to the axis of the
vessel. Stenoses were classified in categories according to
the Strandness criteria11: A (0%), B (1% to 15%), C (16% to
49%), D (50% to 79%), D (80% to 99%), and E (occlu-
sion). This classification has been validated with angiogra-
phy, with overall accuracy documented at 90%. For 60%
stenosis, sensitivity of 93%, specificity of 98%, and positive
and negative predictive values of 96.4% and 95.7%, respec-
tively, have been reported from this laboratory.12,13 An
internal carotid artery stenosis was deemed not measurable
when proximal disease of the common carotid artery was
present.
Outcomes. The main outcome studied was progres-
sion of the internal carotid artery stenosis at a 6-month to
9-month interval.
Statistical analyses. Because findings in the two ca-
rotid arteries of the same patient are not independent
observations (an individual patient has a constellation of
known and unknown variables affecting the incidence,
progression, and clinical manifestations of carotid disease),
results are reported for right and left carotid arteries sepa-
rately, rather than as a total number of carotids (when the
artery is the unit of analysis), and by most severe stenosis
(for those analyses where the patient is the unit of analysis).
Progression of stenosis was defined as a change from one
classification of the Washington criteria to a more severe
classification of stenosis. Baseline characteristics of patients
with, and without, follow-up data were compared. Data
were analyzed with the statistical software SPSS, version 9
(SPSS Inc, Chicago, Ill). Continuous variables are ex-
pressed as mean  standard deviation. For categoric vari-
ables, differences between groups were studied with 2
analysis, with Kendall  for ranked data, or with Mann-
Whitney U test, as appropriate. Spearman correlation coef-
ficient was used to assess relationships between ranked data.
P values equal to or less than .05 were considered statisti-
cally significant, and all tests were two-tailed. Univariate
analysis (Mann-Whitney U test) and logistic regression
were used to identify subgroups of patients who had an
increased prevalence of significant carotid stenosis.
RESULTS
Population characteristics. From July 1999 to De-
cember 2000, 620 patients met inclusion criteria and un-
derwent at least one duplex scan, and of these, 417 had
undergone at least one follow-up carotid duplex scan after
a 6-month to 9-month interval. The remaining 203 pa-
tients did not return for follow-up examination. A total of
417 patients were therefore available for assessment of the
progression of disease. At the time of the first examination,
the average age was 72 10 years (range, 27 to 101 years),
and 60.6% were men. Risk factors for atherosclerotic dis-
ease are reported in Table I.
Degree of carotid stenosis. Of the 620 patients, 30
(4.8%) had an occluded internal carotid artery. The degree
of stenosis could not be established with duplex scan in 16
arteries (1.3%) in 14 patients (two patients had unmeasur-
able arteries bilaterally). Table II summarizes the preva-
lence of stenosis in the right and left carotid arteries at
baseline: no differences between the two sides were ob-
served. The prevalence rates of stenosis 50% were 20%
and 25% for the right and left carotid artery, respectively,
and a stenosis of this degree of severity was observed in 199
patients (33%).
No patients younger than 50 years of age were found to
have stenosis 50%. Table III shows the increasing preva-
lence of high-degree stenosis (D and D) observed with
Table I. Risk factors for atherosclerotic disease
Current smoking 404 (65.2%)
Diabetes 134 (21.6%)
Hypertension 367 (59.2%)
Angina 79 (12.7%)
Myocardial infarction 213 (34.4%)
Arrhythmia 45 (7.3%)
Stroke* 139 (22.4%)
Ankle/brachial index (mean [SD];
minimum-maximum)
Right 0.78 (0.22); 0.2-1.7
Left 0.76 (0.24); 0.1-1.8
Lowest 0.68 (0.23); 0.1-1.0
After treadmill, right 0.70 (0.29); 0.1-1.4
After treadmill, left 0.74 (0.28); 0.2-1.8
After treadmill, lowest 0.61 (0.28); 0.1-2.0
*More than 3 years before entering the study.
SD, Standard deviation.
Table II. Degree of carotid stenosis
Class stenosis
Right carotid Left carotid
No. No.
A (0%) 48 (7.7%) 44 (7.1%)
B (1% - 15%) 148 (23.9%) 128 (20.6%)
C (16% - 49%) 273 (44%) 267 (43.1%)
D (50% - 79%) 119 (19.2%) 145 (23.4%)
D (80% - 99%) 7 (1.1%) 13 (2.1%)
E (Occluded) 18 (2.9%) 14 (2.3%)
Not measurable 7 (1.1%) 9 (1.5%)
Total 620 620
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each decade (Spearman rho for the association between age
and degree of stenosis, 0.144; P  .001).
No difference was found between male and female
gender for any of the categories of internal carotid artery
stenosis (P  .85). Overall, a trend was seen towards higher
degrees of carotid stenosis in patients with diabetes com-
pared with those without diabetes (P .07). Severe steno-
sis (50%) was observed in 54 of 123 patients with diabetes
(44%) compared with 145 of 453 patients without diabetes
(32%; 2  5.5; P  .01).
A multivariable analysis was conducted with age, sex,
smoking history, diabetes, hypertension, angina, history of
myocardial infarction, presence of arrhythmia, history of
stroke, and ankle/brachial index less than 0.8 in a stepwise
logistic regression model, with stenosis50% (most severe
stenosis) as the dependent variable. Age (P .007), diabe-
tes mellitus (P  .042), history of stroke (P  .011) , and
ankle/brachial index less than 0.8 (P  .001) were associ-
ated with increased presence of a stenosis50% (Table IV).
A graded relationship between the ankle-brachial index and
the presence of severe carotid stenosis (50%) also was
observed, which was highly statistically significant (Kendall
  0.001 for trend; Table V). Table VI summarizes the
prevalence of internal carotid artery stenosis50% for each
of the independent variables found to be statistically asso-
ciated with an increased prevalence of severe stenosis in the
multivariate model. Because the odds ratios (ORs) associ-
Table V. Relationship between prevalence of stenosis in
most severely affected carotid and lowest ankle/brachial
index at baseline for all patients
Ankle/brachial index
Severity of carotid stenosis
A, B or C (50%) D/D (50%)
0.4 19 (41%) 27 (59%)
0.4 - 0.59 101 (61%) 64 (39%)
0.6 - 0.79 82 (57%) 63 (43%)
0.8 199 (75%) 65 (25%)
Table VI. Prevalence of internal carotid artery stenosis
50% and risk factors
Internal carotid artery stenosis 50%
Age 70 years 159/389 (41.0%)
Diabetes 61/134 (45.5%)
History of stroke 64/139 (46.0%)
Ankle/brachial index 0.80 154/358 (43.0%)
Table III. Degree of stenosis of worst carotid in 576 patients and age
Age (y)
Degree of stenosis
A (0%) B (1% - 15%) C (16% - 49%) D (50% - 79%) D (80% - 99%) Occluded D/D (50%)
 40 1 (50%) 1 (50%) – – – – –
40 - 49 5 (38.5%) 4 (30.8%) 4 (30.8%) – – – –
50 - 59 2 (3.5%) 12 (21.1%) 22 (38.6%) 12 (21.1%) 4 (7.0%) 5 (8.8%) 16 (28%)
60 - 69 6 (3.8%) 29 (18.6%) 78 (50.0%) 36 (23.1%) 2 (1.3%) 5 (3.2%) 38 (24%)
70 - 79 8 (3.2%) 36 (14.3%) 101 (40.2%) 88 (35.1%) 5 (2.0%) 13 (5.2%) 93 (37%)
80 3 (2.4%) 16 (12.6%) 49 (38.6%) 48 (37.8%) 4 (3.1%) 7 (5.5%) 251 (41%)
Total 25 (4.1%) 98 (16.2%) 254 (41.9%) 184 (30.4%) 15 (2.5%) 30 (5.0%) 199 (33%)
Table IV. Logistic regression model for dependent variable, internal carotid artery stenosis 50%
Independent
variable 
Standard
error P value
Correlation
coefficient (R) Odds ratio
Age 0.0261 0.0097 .007 0.0810 1.0264
Diabetes 0.4262 0.2099 .0423 0.0514 1.5314
History of
stroke
0.5173 0.2043 .0113 0.0740 1.6774
Ankle/brachial
index .80
0.6451 0.1872 .0006 0.1107 1.9062
Gender 0.1412 0.1846 .4443 0.0000 1.1517
Smoking history 0.0904 0.1873 .6292 0.0000 1.0947
Hypertension 0.0194 0.1814 .9148 0.0000 1.0196
Angina 0.3050 0.2631 .2464 0.0000 1.3566
History of
myocardial
infarction
0.1427 0.1935 .4610 0.0000 1.1534
Arrhythmia –0.4565 0.3540 .1972 0.0000 0.6335
Constant –3.2900 0.7342 .0000 – –
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ated with each of these risk factors were similar in magni-
tude, we examined the relationship between the total num-
ber of these risk factors and the prevalence of internal
carotid artery stenosis (Table VII). The prevalence rates of
carotid artery stenosis50% were 17%, 22%, 38%, 47%, and
44% for no, one, two, three, and four risk factors, respec-
tively (Spearman rho, 0.345; P  .001).
Progression of disease. Patients who returned for
follow-up examination, compared with those whose data
were missing at the second time point, were older, had
more severe disease at baseline, and had higher vascular
comorbidity (Table VIII). Among the 417 patients who
returned for follow-up examination, 399 right carotids
were at risk of disease progression (417 minus 12 occluded
and six not measurable). One artery (0.6%) that was not
occluded on the original examination was found to be
occluded on the follow-up examination. Progression
(change from one degree of stenosis to a more severe
degree of stenosis) was observed in 64 of these 399 arteries
(16%) and regression (change from one degree of stenosis
to a less severe stenosis) was seen in eight arteries (2%).
Results are shown in Table IX.
On the 399 left carotid arteries at risk of progression
(417 minus 11 occluded and seven not measurable), 58
progressed (14.5%) and six regressed (1.5%; Table X). No
differences in progression of disease were identified when
the variables of age, diabetes, previous stroke, and ankle/
brachial index of less than 0.8 were studied (data not
Table VII. Number of risk factors and prevalence of increasing severity of internal carotid artery stenosis
Number of risk
factors
Internal carotid artery stenosis
A (0) B (1% - 15%) C (16% - 49%) D (50% - 79%) D (80% - 99%) D/D (50%) Occluded
Not
measurable
0 10 (11.1%) 26 (28.9%) 36 (40%) 11 (12.2%) 4 (4.4%) 15 (16.6%) 3 (3.3%) –
1 11 (6.0%) 35 (19.2%) 92 (50.5%) 39 (21.4%) 1 (0.5%) 40 (21.9%) 3 (1.6%) 1 (0.5%)
2 4 (1.8%) 26 (11.6%) 88 (39.3%) 82 (36.6%) 4 (1.8%) 86 (38.3%) 14 (6.3%) 6 (2.7%)
3 – 9 (8.5%) 34 (32.1%) 45 (42.5%) 5 (4.7%) 50 (47.1%) 8 (7.5%) 5 (4.7%)
4 – 2 (11.1%) 4 (22.2%) 7 (38.9%) 1 (5.6%) 8 (44.4%) 2 (11.1%) 2 (11.1%)
Number of risk factors: one point each for age 70 years, diabetes, history of stroke, and ankle/brachial index 0.80.
Table VIII. Baseline characteristics of patients with and without complete follow-up data
Patients with follow-up data (N  417) Patients without follow-up data (N  203) P value
Age (y) 72.8  9.5 69.6  10.9 .01
Male gender 259 (62%) 117 (57.6%) .87
Current smoking 272 (65%) 132 (65%) .55
Diabetes 93 (22%) 41 (20%) .31
Hypertension 265 (63%) 102 (50%) .99
Angina 65 (16%) 14 (6.9%) .01
Myocardial infarction 158 (38%) 55 (27%) .005
Arrhythmia 39 (9.4%) 6 (3.0%) .002
Stroke* 109 (26%) 30 (15%) .01
Ankle/brachial index 0.80, lowest 269 (65%) 89 (44%) .0001
D/D stenosis (50%) 170 (41%) 49 (24%) .0001
*More than 3 years before entering the study.
Table IX. Right internal carotid artery stenosis: progression
Initial stenosis
Stenosis at second duplex scan
A (0%) B (1% - 15%) C (16% - 49%) D (50% - 79%) D (80% - 99%) E (occluded) Not measurable Total
A (0%) 15 (65.2%)* 5 (21.7%) 3 (13.0%) 23 (5.5%)†
B (1% - 15%) 3 (3.0%) 65 (65.7%) 26 (26.3%) 4 (4.0%) 1 (1.0%) 99 (23.7%)
C (16% - 49%) 2 (1.1%) 155 (86.1%) 22 (12.2%) 1 (0.6%) 180 (43.2%)
D (50% - 79%) 3 (3.2%) 87 (93.5%) 3 (3.2%) 93 (22.3%)
D (80% - 99%) 4 (100%) 4 (1.0%)
E (occluded) 12 (100%) 12 (2.9%)
Not measurable 6 (100%) 6 (1.4%)
Total 18 (4.3%) 72 (17.3%) 187 (44.8%) 113 (27.1%) 7 (1.7%) 13 (3.1%) 7 (1.7%) 417 (100%)
*Percentages in body of table are row percentages (ie, denominator is number of carotid arteries initially in given classification).
†Marginal percentages are percentages of total (ie, denominator is total number of carotid arteries).
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shown). No difference also was found for patients with one
or two risk factors and patients with three or four risk
factors (data not shown).
None of the patients who returned for follow-up du-
plex scanning had an interim carotid endarterectomy or
stent or had ischemic neurologic deficit.
DISCUSSION
Duplex ultrasonography is an effective technique to
diagnose and follow stenoses of the internal carotid artery.
A metaanalysis conducted in 19951 showed that the sensi-
tivity of duplex ultrasonography to detect stenosis 50%
(defined by the gold standard of angiography) was 91%
(95% CI, 89 to 94) and its specificity was 93% (95% CI, 88
to 95). On the basis of the prevalence rate of disease of
about 41% in patients referred for duplex ultrasonography,
this translates into a positive predictive value of 90% and an
accuracy of 92%.1 A more contemporary prospective series
of patients in whom carotid endarterectomy was being
considered (neurologically symptomatic and asymptom-
atic) reported a sensitivity of 100% and a specificity of 98%
for stenosis 60% and a positive predictive value of 99%.2
The identification of patients at risk of carotid stenosis
and of cerebrovascular events is at the basis of a rational and
cost-effective utilization of noninvasive diagnostic tech-
nique in carotid disease. In cross-sectional and population-
based studies, the overall prevalence rate of significant
carotid stenosis 75% is low. O’Leary et al14 reported a
prevalence rate of 2.3% in men and 1.1% in women, and this
rate increased significantly with age (P  .0001) with each
decade from 65 years to more than 85 years from an
incidence rate of 0.8% to 3% without significant differences
between men and women.14 In the Framingham popula-
tion, the incidence rate of stenosis 50% was 8% (95% CI,
6.5% to 9.8%).15 In a study of healthy volunteers 70 years of
age or older, the incidence rate of carotid stenosis 50%
was 5.1% (95% CI, 2.6% to 9.0%) and 1.5% (95% CI, 0.2%
to 5.3%) in younger individuals.5 The low prevalence of
carotid stenosis in the general population does not warrant
screening in unselected patients.
The pooled risk of carotid stenosis  60% to 75% in
patients with carotid bruits referred for noninvasive vascular
evaluation, whose average age was 65 years, was reported at
21% (95% CI, 18 to 24),6-8,16 three to four times the
expected prevalence rate from the population-based studies
discussed previously. Patients with vascular risks or known
peripheral vascular disease also may warrant further consid-
eration on the basis of increased prevalence of significant
carotid stenosis. Hemodynamically significant stenoses
(50%) were found with ultrasound scan in 32% of a
population of patients scheduled to undergo peripheral
vascular surgery.17 This rate is similar to the prevalence rate
(33%) observed in this work.
In patients who are asymptomatic, the absolute benefit
of carotid endarterectomy is small and of borderline statis-
tical significance. In the Asymptomatic Carotid Atheroscle-
rosis Study, the relative risk reduction for ipsilateral major
stroke or perioperative death over 2.7 years was 36.5% (95%
CI, 27.5% to 47.1%) and the absolute risk reduction was
2.3% (95% CI, 0.2% to 7.0%).18 This translates into a
number needed to treat with carotid endarterectomy to
prevent one disabling stroke or death of 43 (95% CI, 14 to
500) and a number needed to screen with Doppler ultra-
sonography, given a prevalence of D or D stenosis in the
worst carotid of 33% (Table III), of 129 to prevent one
stroke over a 3-year period of follow-up study. Given that
many vascular surgeons reserve carotid endarterectomy in
asymptomatic patients for those with the highest degrees of
stenosis (D), who represented only 2.5% of our patients,
the number needed to screen to prevent one stroke at 3
years in this population was approximately 1720. Screening
of patients with claudication or bruits with DUS does not,
therefore, appear to these authors to be warranted.
However, we sought to define, within the population
of patients with peripheral arterial occlusive disease, a sub-
group at sufficiently high risk to warrant routine screening.
Cohort6-8,9,19-22 and population-based14,15,23 studies sug-
gest that patients with bruits are more likely to have signif-
icant carotid stenosis if they are older, hypertensive, and
smokers and have advanced peripheral vascular disease. Any
of these features suggests a prevalence rate of significant
carotid stenosis higher than in the average population with
asymptomatic carotid bruits. The overall prevalence rate of
a stenosis 50% in this cohort of patients was 33% (199/
Table X. Left internal carotid artery stenosis progression
Initial stenosis
Stenosis at second duplex scan
A (0%) B (1% - 15%) C (16% - 49%) D (50% - 79%) D (80% - 99%) E (occluded) Not measurable Total
A (0%) 10 (58.8%)* 3 (17.6%) 4 (23.5%) 17 (4.1%)†
B (1% - 15%) 1 (1.2%) 53 (63.1%) 26 (31.0%) 3 (3.6%) 1 (1.2%) 84 (20.1%)
C (16% - 49%) 1 (0.6%) 4 (2.3%) 148 (85.1%) 20 (11.5%) 1 (0.6%) 174 (41.7%)
D (50% - 79%) 114 (98.3%) 1 (0.9%) 1 (0.9%) 116 (27.8%)
D (80% - 99%) 1 (12.5%) 7 (87.5%) 8 (1.9%)
E (occluded) 11 (100%) 11 (2.6%)
Not measurable 7 (100%) 7 (1.7%)
Total 12 (2.9%) 60 (14.4%) 178 (42%) 138 (33.1%) 8 (1.9%) 12 (2.9%) 9 (2.2%) 417 (100%)
*Percentages in body of table are row percentages (ie, denominator is number of carotid arteries initially in given classification).
†Marginal percentages are percentages of total (ie, denominator is total number of carotid arteries).
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606). None of these patients was younger than 50 years of
age, and the highest prevalence rate was in those older than
80 years (41%). A similar high prevalence rate was observed
in patients with diabetes (44%) and in patients with a
history of stroke (46%). We have further refined these risk
factors with consideration of how they work in combina-
tion and have established a gradient of increasing risk with
increasing numbers of risk factors. For example, a patient
with diabetes with none of the other identified risks (ie, no
prior stroke, age less than 70 years, and ankle/brachial
indices 0.8 bilaterally) has only a 21% risk of stenosis
50%, compared with 44% risk for all patients with diabe-
tes. Severity of peripheral vascular disease alone, as assessed
with the lower ankle/brachial index, was also a predictor of
severity of stenosis: the prevalence rate of carotid stenosis
50% in those with values less than 0.4 was 59% (Table V).
Marek and coworkers16 found that, in patients with ankle/
brachial indices of less than 0.7, age older than 65 years
(OR, 1.3) and presence of a carotid bruit (OR, 1.8) were
predictors of carotid stenoses 50%, and, as in our data,
were gradients of increasing risk if two or three risk factors
were present (age and carotid bruit: OR, 2.5; age, carotid
bruit, and ankle/brachial index 0.7: OR, 5.4). Simons et
al24 have identified age (67 years), low body weight (68
kg), and low diastolic blood pressure (75 mm Hg) to be
independently associated with increased prevalence of ca-
rotid stenosis 50% (8%, 32%, and 50% prevalence rate
when each of these risk factors was present, respectively;
Table XI).
Screening for carotid stenosis in patients who are neu-
rologically asymptomatic may therefore be acceptable (in
patients who are suitable surgical candidates) when two or
more of the risk factors that we or others have identified are
present or when ankle/brachial index is less than 0.4.
Again, however, the operative strategy of the surgeon has a
large impact on this decision. If the strategy is to operate on
patients with 50% stenosis, with the knowledge of these
risk factors to identify a higher risk subpopulation, this will
result in a number needed to screen of only 86. However,
for an interventional strategy of operating only on those
with 80% stenosis, the number needed to screen still
exceeds 1000. For this reason, we believe that the best strategy
is to consider the risk factor profile before requesting DUS
and believe that, even in patients with two or more risk factors,
screening should not be considered mandatory.
We included patients in this study who had had isch-
emic events, including stroke, provided they preceded the
date of study by 3 years or more. This cutpoint was more
conservative than the inclusion criteria for the North Amer-
ican Symptomatic Carotid Endarterectomy Trial,25,26
which included patients whose ipsilateral neurologic events
had occurred within 2 years of the study. Compared with
patients in whom the benefits of carotid endarterectomy for
asymptomatic stenosis were studied, our population differs
Table XI. Prevalence of carotid stenosis
Authors
Lewis et al34* Marek et al16† Simons et al24‡ Garvey et al36§ Present study
Degree of stenosis Percentage within category
A and B (0% - 15%) 34 67 57 29
C (16% - 49%) 16 8 18 43
D (50% - 79%) 29 20 14 (D and D) 14 22
D (80% - 99%) 16 1.6 10 1
E (occluded) 5 2.7 0 3
*Patients with cervical bruits.
†Patients with claudication.
‡Patients with evidence of vascular disease.
§Patients from Veterans Affairs hospital.
Table XII. Annualized progression of carotid stenosis
Lewis et al34 Mansour et al33 Rockman et al31 Muluk et al30 Present study*
Stenosis category on follow-up study
D,D D, E D,E D D,D,E D E D,D D
Initial stenosis
A, B (0% - 15%) 1.3 0.2 3 13.5
C (16% - 49%) 8.4 1.1 10.9
D (50% - 79%) 11.1 8.5 5.7 12.2 3.8
D (80% - 99%) 6.5 7.7
*These rates of progression are calculated on per-patient basis and annualized by multiplying observed rate of progression (over 6 - 9 months) by 2.
JOURNAL OF VASCULAR SURGERY
July 200280 Cina` et al
in two ways. Firstly, patients with remote events contralat-
eral to the stenosis of interest, who would have been included
in ACAS,18 have been excluded from our study. Secondly,
ACAS excluded patients who were ever symptomatic in the
territory of the stenosed carotid. The diagnosis of previous
ischemic neurologic events with history and examination is
known to be subject to high interobserver variability.27 The
differentiation between vertebrobasilar and carotid events
(and thus the lateralization of the neurologic lesion causing a
focal paresis) is similarly subject to high interobserver varia-
tion, even among neurologists.28 Data in this study were
collected by a registered vascular technologist; we believed
that the most reliable way of operationalizing the concept of
“asymptomatic” stenosis was to exclude all patients with any
symptoms in the previous 3 years.
A second question of interest is the rate of progression
of asymptomatic disease. Reported risk for progression
ranges between 0.2% and 20% each year (Table XII) and
varies according to initial degree of stenosis, risk factors
profiles, and between studies. Guidelines have suggested
that duplex scanning be repeated at 6 monthly intervals29
for patients who have an asymptomatic carotid stenosis
60% who do not undergo surgery. We examined a
6-month to 9-month follow-up period, similar to the inter-
val suggested in current guidelines.29 In our large study of
a high-risk population, progression from any classification
to a higher classification of stenosis occurred in 15% of
arteries. However, we believe that the more relevant ques-
tion is what proportion of patients progresses to a category
that leads to a change in management from medical to
surgical. Depending on the surgical strategy, the clinically
relevant data could be the proportion of patients progress-
ing to D or D or the proportion progressing to D. Of all
the patients whose most severely affected artery was initially
in classification A to C, 6.5% progressed to having at least
one artery classification D or D during the follow-up
period. Of patients who initially had an artery in classifica-
tion D (208 patients), four progressed to D (1.9%). Table
XII summarizes these data and other studies of progression
of carotid disease. We were unable to identify any risk
factors for progression to allow a more focused approach.
This may be the result of the low power of our study to
identify risks, given the low progression rates that we
observed during the time period of our study.
Measurement error must be considered when studying
progression and regression. In studies of carotid progres-
sion, a small but important percentage of patients are
reported to have a stenosis of lesser severity at the second
measurement compared with the baseline. Although re-
gression of carotid stenosis is possible, the inherent meas-
urement error associated with DUS, even in the best labo-
ratory, is more likely to account for this finding. This
observation leads to the consideration that a proportion of
those patients classified as having progressed are also likely
misclassified because of measurement error.
No neurologic events were reported in the patients
who returned for follow-up study, but given the short
duration of the study, which was not designed to address
this question, we do not believe this adds significantly to
the information available about the natural history of this
disease. The association of progression with stroke has been
cited as a rationale for repeated follow-up DUS in patients
with low degree of stenosis. Closer examination of the
available data calls this in question. Two studies of this
question censored patients at the time of progression30,31;
the reported strokes therefore had preceded the ultrasound
scan documentation of progression. Because sudden nar-
rowing of a carotid artery (for example associated with
plaque rupture or hemorrhage) is a biologically plausible
mechanism in the genesis of atheroembolic stroke,32 it is
unsurprising that these investigators were able to document
an association between progression and stroke. However,
because the strokes preceded the recognition of progres-
sion, these data do not support the use of routine DUS
monitoring for evidence of progression as a useful prognos-
tic tool. In the single study that reported strokes before and
after documentation of progression,33 seven strokes oc-
curred in 142 patients, six in patients with progression.
However, four of these events preceded documentation of
progression. Lewis and coworkers34 used a modeling ap-
proach and concluded that although progression to 80%
stenosis was associated with increased risk of cerebrovascu-
lar events and death, the sensitivity and positive predictive
value of this finding were low.
In summary, we believe that our study suggests that
screening for asymptomatic stenosis in patients with vascu-
lar risks is acceptable if two or more clinical risk factors are
present or if ankle/brachial index is less than 0.4. We and
other investigators have identified combinations of risks
that identify populations in whom the risk of stenosis
between 50% and 99% approaches 60%. Screening patients
in these categories who are suitable operative candidates
and who would undergo operation were they found to have
clinically important disease may therefore be a reasonable
approach. However, even with this approach, the propor-
tion of patients who have very high degree stenosis (80% to
99% stenosis) is still likely to be less than 10% and the
absolute benefits of surgery are small.18 For these reasons,
on the basis of currently available data, we believe that
screening should not be considered mandatory. Further
information on the risks and benefits of carotid endarterec-
tomy in patients who are asymptomatic will be available
with the results of the Asymptomatic Carotid Surgery Tri-
al,35 which may modify these conclusions. With respect to
follow-up evaluations of patients identified as having lower
grades of stenosis, we found that the risk of progression
after a 6-month to 9-month interval was low. If the object
is to identify patients who have progressed to the 80% to
99% category to offer prophylactic carotid endarterectomy
(with the previous caveats about operability and preferenc-
es), on the basis of current data, we suggest that reevalua-
tion is not mandatory at 6 months as currently advocated.29
Further research to identify the optimal population for
reevaluation, and the optimal interval, is needed.
The interpretation of results in this study is limited by
the ultrasonographic criteria used to define carotid stenosis
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and by the relatively short follow-up period. A more accu-
rate measure of carotid stenosis, definition of plaque mor-
phology, and larger studies with longer follow-up time will
improve our understanding of this condition. At present,
however, screening seems acceptable, though not mandatory,
only if two or more risk factors for atherosclerotic disease are
coexistent and reevaluation should be limited to high-grade
stenosis and follow-up at an interval greater than 6 months.
We thank W. Herod, D. Boyce, E. Pawlett, S. Gibbons,
and S. McLaughlin for contributing to the careful collec-
tion of data in this cohort of patients. Without their con-
tribution, this work could not have been possible.
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